ArticleRadiation oncology (London, England)2022

Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study.

Jian-Xu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.